Melinda C Power1, Jennifer A Deal2, A Richey Sharrett2, Clifford R Jack2, David Knopman2, Thomas H Mosley2, Rebecca F Gottesman2. 1. From the Department of Neurology, Johns Hopkins University School of Medicine (R.F.G.), and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (M.C.P., J.A.D., A.R.S., R.F.G.), Baltimore, MD; Departments of Radiology (C.R.J.) and Neurology (D.K.), Mayo Clinic, Rochester, MN; and Department of Medicine (T.H.M.), University of Mississippi Medical Center, Jackson. melindacpower@gmail.com. 2. From the Department of Neurology, Johns Hopkins University School of Medicine (R.F.G.), and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (M.C.P., J.A.D., A.R.S., R.F.G.), Baltimore, MD; Departments of Radiology (C.R.J.) and Neurology (D.K.), Mayo Clinic, Rochester, MN; and Department of Medicine (T.H.M.), University of Mississippi Medical Center, Jackson.
Abstract
OBJECTIVE: Our objective was to examine the link between smoking and smoking history, including smoking intensity and cessation, overall and by race, in a biracial prospective cohort study. METHODS: A subset of Atherosclerosis Risk in Communities Study participants (n = 972, 49% black) completed brain MRI scans twice (1993-1995 and 2004-2006). We defined white matter hyperintensity (WMH) progression as an increase of ≥2 points on the 9-point Cardiovascular Health Study scale across scans. Participants reported information on smoking behavior at the baseline MRI and at 2 prior study visits, approximately 3 and 6 years before baseline. We used adjusted logistic regression to evaluate the association between smoking variables and WMH progression in the total sample and separately by race (black and white). RESULTS: We found WMH progression in 23% of participants (30% of black participants, 17% of white participants). Overall, being a current smoker 6 years before baseline was associated with WMH progression. In race-stratified analyses, we found adverse associations with smoking status at multiple time points and persistent smoking in white but not in black participants. However, we found no statistical support for effect modification by race for most of these analyses. Increasing pack-years of smoking was associated with greater risk of WMH progression, while time since quitting and age at smoking initiation were not associated with WMH progression, with little indication of differences in these associations by race. CONCLUSIONS: Our findings concur with previous studies suggesting a relationship between smoking and WMH progression, and further demonstrate a dose-dependent association.
OBJECTIVE: Our objective was to examine the link between smoking and smoking history, including smoking intensity and cessation, overall and by race, in a biracial prospective cohort study. METHODS: A subset of Atherosclerosis Risk in Communities Study participants (n = 972, 49% black) completed brain MRI scans twice (1993-1995 and 2004-2006). We defined white matter hyperintensity (WMH) progression as an increase of ≥2 points on the 9-point Cardiovascular Health Study scale across scans. Participants reported information on smoking behavior at the baseline MRI and at 2 prior study visits, approximately 3 and 6 years before baseline. We used adjusted logistic regression to evaluate the association between smoking variables and WMH progression in the total sample and separately by race (black and white). RESULTS: We found WMH progression in 23% of participants (30% of black participants, 17% of white participants). Overall, being a current smoker 6 years before baseline was associated with WMH progression. In race-stratified analyses, we found adverse associations with smoking status at multiple time points and persistent smoking in white but not in black participants. However, we found no statistical support for effect modification by race for most of these analyses. Increasing pack-years of smoking was associated with greater risk of WMH progression, while time since quitting and age at smoking initiation were not associated with WMH progression, with little indication of differences in these associations by race. CONCLUSIONS: Our findings concur with previous studies suggesting a relationship between smoking and WMH progression, and further demonstrate a dose-dependent association.
Authors: Jennifer Weuve; Eric J Tchetgen Tchetgen; M Maria Glymour; Todd L Beck; Neelum T Aggarwal; Robert S Wilson; Denis A Evans; Carlos F Mendes de Leon Journal: Epidemiology Date: 2012-01 Impact factor: 4.822
Authors: W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried Journal: Stroke Date: 1996-08 Impact factor: 7.914
Authors: W T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles Jungreis; Calvin H Hirsch; Daniel H O'Leary; Curt D Furberg Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: M L Bots; J C van Swieten; M M Breteler; P T de Jong; J van Gijn; A Hofman; D E Grobbee Journal: Lancet Date: 1993-05-15 Impact factor: 79.321
Authors: Rebecca F Gottesman; Josef Coresh; Diane J Catellier; A Richey Sharrett; Kathryn M Rose; Laura H Coker; Dean K Shibata; David S Knopman; Clifford R Jack; Thomas H Mosley Journal: Stroke Date: 2009-11-19 Impact factor: 7.914
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Stroke Date: 2004-06-24 Impact factor: 7.914
Authors: Dean Shibata; Astrid Suchy-Dicey; Cara L Carty; Tara Madhyastha; Tauqeer Ali; Lyle Best; Thomas J Grabowski; W T Longstreth; Dedra Buchwald Journal: Neuroepidemiology Date: 2019-06-04 Impact factor: 3.282
Authors: Adam de Havenon; Chelsea Meyer; J Scott McNally; Matthew Alexander; Lee Chung Journal: Curr Atheroscler Rep Date: 2019-07-27 Impact factor: 5.113
Authors: David Della-Morte; Chuanhui Dong; Matthew S Markert; Mitchell S V Elkind; Ralph L Sacco; Clinton B Wright; Tatjana Rundek Journal: Stroke Date: 2017-12-28 Impact factor: 7.914
Authors: Eugene L Scharf; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Michelle M Mielke; David S Knopman; Gregory M Preboske; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Mary Machulda; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri Journal: Stroke Date: 2019-09-12 Impact factor: 7.914
Authors: Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman Journal: JAMA Neurol Date: 2018-11-01 Impact factor: 18.302
Authors: Bernhard Haring; Adam Omidpanah; Astrid M Suchy-Dicey; Lyle G Best; Steven P Verney; Dean K Shibata; Shelley A Cole; Tauqeer Ali; Barbara V Howard; Dedra Buchwald; Richard B Devereux Journal: Hypertension Date: 2017-09-11 Impact factor: 10.190
Authors: Jennifer A Deal; Melinda C Power; Priya Palta; Alvaro Alonso; Andrea L C Schneider; Kelly Perryman; Karen Bandeen-Roche; A Richey Sharrett Journal: J Am Geriatr Soc Date: 2019-11-01 Impact factor: 5.562
Authors: Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Anna M Kucharska-Newton; Juebin Huang; Clifford R Jack; Rebecca F Gottesman Journal: Neurology Date: 2019-01-25 Impact factor: 9.910